Clinical trial
Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic…
NCT00032162 · AGO Study Group, Other · Completed
Key facts
| NCT number | NCT00032162 |
|---|---|
| Title | Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer |
| Official title | Phase I/II Trial, Dose Finding Combination Chemotherapy With PegLiposomal Doxorubicin (PLD) And Carboplatin In Patients With Gynecologic Tumors |
| Lead sponsor | AGO Study Group, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Cervical Cancer, Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer, Sarcoma |
| Intervention type | Drug |
| Interventions | carboplatin, pegylated liposomal doxorubicin hydrochloride |
| Enrollment | 63 |
| Start date | Aug 1, 2001 |
| Primary completion | May 1, 2005 |
| First posted | Jan 27, 2003 |
| Last update posted | May 31, 2012 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: